menu
    • menu

    Company profile for Ardelyx

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are focused on developing and bringing to market first in class medicines to better the lives of underserved patients with cardiorenal diseases. It’s the patients in need that motivate and inspire us to be relentless and work hard every day. They push us to maintain a clear focus on scientific and clinical integrity with a commitment to medical innovation so that we can deliver exceptional medicines. We are committed to ...
    We are focused on developing and bringing to market first in class medicines to better the lives of underserved patients with cardiorenal diseases. It’s the patients in need that motivate and inspire us to be relentless and work hard every day. They push us to maintain a clear focus on scientific and clinical integrity with a commitment to medical innovation so that we can deliver exceptional medicines. We are committed to bringing effective medicines to underserved patients by using the gut as the gateway to better health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArdelyxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    34175 Ardenwood Blvd Suite 200 Fremont, CA 94555
    Telephone
    Telephone
    (510) 745-1700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ardelyx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ardelyx-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ardelyx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ardelyx Presents XPHOZAH Long-Term Safety at NKF Spring Meetings
    Ardelyx Presents XPHOZAH Long-Term Safety at NKF Spring Meetings

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3289968/0/en/ardelyx-presents-analysis-supporting-long-term-safety-of-xphozah-at-nkf-s-spring-clinical-meetings.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Ardelyx Unveils Q1 2026 Financials And Business Update
    Ardelyx Unveils Q1 2026 Financials And Business Update

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257112

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    Ardelyx To Present Poster At NKF Spring Clinical Meetings
    Ardelyx To Present Poster At NKF Spring Clinical Meetings

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281589/0/en/ardelyx-announces-abstract-accepted-for-poster-presentation-at-the-nkf-s-spring-clinical-meetings.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Ardelyx Abstract On IBS-C Treatment Patterns Accepted
    Ardelyx Abstract On IBS-C Treatment Patterns Accepted

    23 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7205716

    FIRSTWORD PHARMA
    23 Apr 2026
    Share Share
    Ardelyx Names Felecia W. Ettenberg Chief Legal Officer
    Ardelyx Names Felecia W. Ettenberg Chief Legal Officer

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276943/0/en/ardelyx-appoints-biopharmaceutical-veteran-felecia-w-ettenberg-as-chief-legal-officer.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    Ardelyx To Release Q1 2026 Financial Results On April 30
    Ardelyx To Release Q1 2026 Financial Results On April 30

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275312/0/en/Ardelyx-to-Report-First-Quarter-2026-Financial-Results-on-April-30-2026.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search